Zealand Pharma Statistics
Total Valuation
Zealand Pharma has a market cap or net worth of 4.51 billion. The enterprise value is 2.01 billion.
| Market Cap | 4.51B |
| Enterprise Value | 2.01B |
Important Dates
The next estimated earnings date is Thursday, February 19, 2026.
| Earnings Date | Feb 19, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +12.73% |
| Shares Change (QoQ) | -1.97% |
| Owned by Insiders (%) | 0.36% |
| Owned by Institutions (%) | 38.10% |
| Float | 55.91M |
Valuation Ratios
The trailing PE ratio is 4.39.
| PE Ratio | 4.39 |
| Forward PE | n/a |
| PS Ratio | 3.14 |
| PB Ratio | 1.90 |
| P/TBV Ratio | 1.90 |
| P/FCF Ratio | 3.90 |
| P/OCF Ratio | 3.89 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 1.78, with an EV/FCF ratio of 1.73.
| EV / Earnings | 1.96 |
| EV / Sales | 1.38 |
| EV / EBITDA | 1.78 |
| EV / EBIT | 1.79 |
| EV / FCF | 1.73 |
Financial Position
The company has a current ratio of 14.10, with a Debt / Equity ratio of 0.03.
| Current Ratio | 14.10 |
| Quick Ratio | 14.10 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.06 |
| Debt / FCF | 0.06 |
| Interest Coverage | 233.70 |
Financial Efficiency
Return on equity (ROE) is 54.42% and return on invested capital (ROIC) is -294.62%.
| Return on Equity (ROE) | 54.42% |
| Return on Assets (ROA) | 33.44% |
| Return on Invested Capital (ROIC) | -294.62% |
| Return on Capital Employed (ROCE) | 45.27% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 3.27M |
| Profits Per Employee | 2.34M |
| Employee Count | 440 |
| Asset Turnover | 0.69 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Zealand Pharma has paid 90.00 million in taxes.
| Income Tax | 90.00M |
| Effective Tax Rate | 8.05% |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 25.53 |
| Average Volume (20 Days) | 252 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Zealand Pharma had revenue of 1.44 billion and earned 1.03 billion in profits. Earnings per share was 14.40.
| Revenue | 1.44B |
| Gross Profit | 1.44B |
| Operating Income | 1.11B |
| Pretax Income | 1.12B |
| Net Income | 1.03B |
| EBITDA | 1.11B |
| EBIT | 1.11B |
| Earnings Per Share (EPS) | 14.40 |
Balance Sheet
The company has 2.54 billion in cash and 63.85 million in debt, with a net cash position of 2.48 billion.
| Cash & Cash Equivalents | 2.54B |
| Total Debt | 63.85M |
| Net Cash | 2.48B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 2.38B |
| Book Value Per Share | 33.89 |
| Working Capital | 2.43B |
Cash Flow
In the last 12 months, operating cash flow was 1.16 billion and capital expenditures -2.78 million, giving a free cash flow of 1.16 billion.
| Operating Cash Flow | 1.16B |
| Capital Expenditures | -2.78M |
| Free Cash Flow | 1.16B |
| FCF Per Share | n/a |
Margins
Gross margin is 99.99%, with operating and profit margins of 77.23% and 71.47%.
| Gross Margin | 99.99% |
| Operating Margin | 77.23% |
| Pretax Margin | 77.73% |
| Profit Margin | 71.47% |
| EBITDA Margin | 77.35% |
| EBIT Margin | 77.23% |
| FCF Margin | 80.57% |
Dividends & Yields
Zealand Pharma does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -12.73% |
| Shareholder Yield | -12.73% |
| Earnings Yield | 22.77% |
| FCF Yield | 25.67% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Zealand Pharma has an Altman Z-Score of 17.81 and a Piotroski F-Score of 6.
| Altman Z-Score | 17.81 |
| Piotroski F-Score | 6 |